| HOME >> BIOLOGY >> TECHNOLOGY |
Retained earnings 737,596 778,932 111,086
Accumulated other comprehensive
loss (71,720) (93,873) (13,387)
Total shareholders' equity 2,728,348 2,768,484 394,821
Total liabilities and shareholders'
equity 3,258,599 3,492,390 498,059
(1) All translations from Renminbi to US dollars as of and for the quarter
ended March 31, 2008 were made at the noon buying rate of the Federal
Reserve Bank of New York as of March 31, 2008, which was RMB7.012 to
US$1.00
Exhibit 2
MINDRAY MEDICAL INTERNATIONAL LIMITED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three months ended March 31,
2007 2008 2008
RMB RMB US$
(unaudited) (unaudited) (unaudited)
(In thousands, except share
and per share data)
Net revenues
- PRC 208,543 306,388 43,695
- International 213,866 319,605 45,580
Net revenues 422,409 625,993 89,275
Cost of revenues (note 2) (185,282) (272,101) (38,805)
Gross profit 237,127 353,892 50,469
Selling expenses (note 2) (48,050) (75,065) (10,705)
General and administrative
expenses (note 2) (23,168) (18,720) (2,670)
Research and development
expenses (note 2)
'/>"/>
| SOURCE Mindray Medical International Limited Copyright©2008 PR Newswire. All rights reserved |